Literature DB >> 19632720

Nilotinib post-liver transplantation for acute hepatic failure related to imatinib.

Guilherme F Perini1, Fabio P S Santos, Vaneuza Funke, Jefferson Ruiz, Ben-Hur Ferraz Neto, Nelson Hamerschlak.   

Abstract

This is the case report of a 47-year-old woman referred to our institution due to acute liver failure related to imatinib, who was submitted to a successful liver transplantation. Nilotinib was safely used post-transplant.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19632720     DOI： 10.1016/j.leukres.2009.06.012

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  6 in total

1.  Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity.

Authors:  Lars Harbaum; Andreas Marx; Eray Goekkurt; Philippe Schafhausen; Djordje Atanackovic
Journal:  Int J Hematol       Date:  2013-11-22       Impact factor: 2.490

Review 2.  European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

Authors:  J L Steegmann; M Baccarani; M Breccia; L F Casado; V García-Gutiérrez; A Hochhaus; D-W Kim; T D Kim; H J Khoury; P Le Coutre; J Mayer; D Milojkovic; K Porkka; D Rea; G Rosti; S Saussele; R Hehlmann; R E Clark
Journal:  Leukemia       Date:  2016-04-28       Impact factor: 11.528

Review 3.  Imatinib-induced fulminant liver failure in chronic myeloid leukemia: role of liver transplant and second-generation tyrosine kinase inhibitors: a case report.

Authors:  Lucas Souto Nacif; Daniel R Waisberg; Rafael Soares Pinheiro; Fabiana Roberto Lima; Vinicius Rocha-Santos; Wellington Andraus; Luiz Carneiro D'Albuquerque
Journal:  J Med Case Rep       Date:  2018-03-10

4.  A Case of Severe, Nilotinib-Induced Liver Injury.

Authors:  Yuliya Belopolsky; David L Grinblatt; Henry M Dunnenberger; Linda M Sabatini; Nora E Joseph; Claus J Fimmel
Journal:  ACG Case Rep J       Date:  2019-02-25

5.  Tumor lysis syndrome soon after treatment with hydroxyurea followed by nilotinib in two patients with chronic-phase chronic myelogenous leukemia.

Authors:  Jian Hua; Yasunobu Iwaki; Morihiro Inoue; Masao Hagihara
Journal:  Int J Hematol       Date:  2013-05-07       Impact factor: 2.490

6.  Сase Report of Acute Toxic Imatinib-induced Hepatitis in a Patient with Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis.

Authors:  Nataliia Lopina; Iryna Dyagil; Dmytro Hamov; Larysa Zhuravlyova; Iryna Dmytrenko; Dmytro Lopin; Kuznetsov Igor
Journal:  Cureus       Date:  2018-08-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.